Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.
about
Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and ClearanceNanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and FeaturesWound repair: role of immune-epithelial interactionsPharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type DietThe restorative role of annexin A1 at the blood-brain barrier.Immune cell screening of a nanoparticle library improves atherosclerosis therapyInflammation-a Critical Appreciation of the Role of Myeloid CellsShifting the Focus of Preclinical, Murine Atherosclerosis Studies From Prevention to Late-Stage Intervention.Recent insights into the cellular biology of atherosclerosisAtherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications.Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory capacity?Towards programming immune tolerance through geometric manipulation of phosphatidylserine.Macrophage Apoptosis and Efferocytosis in the Pathogenesis of AtherosclerosisHyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in AtherosclerosisDegradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.The Role of Efferocytosis in Atherosclerosis.Cytokines: roles in atherosclerosis disease progression and potential therapeutic targetsMicro-RNAs and macrophage diversity in atherosclerosis: new players, new challenges…new opportunities for therapeutic intervention?Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity.Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.Macrophage Phenotype and Function in Different Stages of Atherosclerosis.Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.Targeting and therapeutic peptides in nanomedicine for atherosclerosis.An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.Inflammation and plaque vulnerability.Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.Applying nanomedicine in maladaptive inflammation and angiogenesis.Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.Delivery strategies to control inflammatory response: Modulating M1-M2 polarization in tissue engineering applications.Inflammatory processes in cardiovascular disease: a route to targeted therapies.Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.Annexin A1: shifting the balance towards resolution and repair.E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.Bolstering cholesteryl ester hydrolysis in liver: A hepatocyte-targeting gene delivery strategy for potential alleviation of atherosclerosis.Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response.Local Inhibition of Macrophage and Smooth Muscle Cell Proliferation to Suppress Plaque Progression.The advantageous role of annexin A1 in cardiovascular disease.Smart Radiation Therapy Biomaterials.The walking dead: macrophage inflammation and death in atherosclerosis.
P2860
Q26765186-52B1A217-EA23-4644-8984-DD03AFBABB2BQ26798426-C631E70C-9B8B-47E5-BC81-3DF1D371858EQ26801818-D38E7201-8259-4421-BC8D-66706684F24BQ27303970-96DE3CD8-763B-4E53-8405-5534658D304BQ27687514-C3E28CEC-EE7C-42C8-869A-69D867C4A42DQ28393434-DC10E69A-9BEB-4142-9604-1D97B7724034Q28595434-819C4DF7-F0D3-47AB-B92E-D6D18E45AF9FQ30253052-1A9CBAF0-4731-4060-B914-C5B70C07CD1CQ30300194-753592A5-0D2F-4B9E-B14F-08BE9B607798Q30364399-C3E05FFE-CE55-4BA0-AE57-8322C39EC87DQ30661665-2FE4D34B-0C92-45AC-A264-7152268018C0Q30751004-5C0DEFB5-FE6D-480C-8D55-6D38F7EA8526Q33764821-43D1FA55-6E54-40BB-87D7-F4473EECFE9BQ33856678-67CAA680-034F-4331-B50C-B8DF897605AAQ33902253-B5D5233A-65CD-4050-93D6-C777A042BF2EQ34680660-F5632E52-6AD7-4FFF-A491-063CF68E1BF4Q36064353-9C317B78-CF11-41E6-A0EB-0B3C455D7877Q36125865-7405585D-DA39-48A3-82EE-E4393A66ED03Q36318569-AF0256CA-758B-467D-B4F7-70F85E358AFBQ36396054-1C009E38-8520-4C50-81A7-E83757265C55Q36602809-381F34B8-BC63-4656-ACE5-8BD57981312AQ36848196-D38229DF-031A-44D1-8223-0CBF8A29D914Q36913594-B07AED07-6CD1-43EF-A4F0-A89593BA7BF4Q37282266-5F81B25C-A49F-4244-81FF-7CFD6CCE3F9DQ37370224-793EF22C-35C8-4174-8385-4BC553C23B9CQ37544674-9427FF92-A641-4EA4-B38D-5358B7370C7BQ37603197-F5B20E70-ADF4-4A5B-987B-1A6F9FA2AA21Q38557650-DF9B2337-6851-4EDB-A747-B11A40740A4AQ38681468-0D66B22D-8EB7-471B-9A3A-0166A4B03FD2Q38700498-409EBD5F-995E-44A0-A832-77D7AB109CE4Q38788685-8FC4B79F-71D8-4985-8C6D-C8B6ABEAB18FQ38828033-8E1E74C5-BEDF-4F43-BB8C-B98110EFC5B3Q38846007-891B9779-B71F-4905-91D6-26490BCF9058Q38858690-D6CF9F27-325B-4FC4-AB63-BCFAC27BA260Q38871582-2FD79EAF-3862-4681-8D5B-07BD447AE6AFQ38962381-BDBB3BCC-02A3-4A30-BE8F-CBFBF48A1119Q39003364-D44F65BC-1EE0-4B16-BFE8-CB5EDEF3ACC1Q39012576-79C51844-7576-4384-85B4-7AADAB765F81Q39105322-5479BA56-EFF0-4476-98B1-4207D4A3A3C8Q39109119-6BA85A1A-6C63-4095-8C91-B6D56D43E7F1
P2860
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeted nanoparticles contain ...... in hypercholesterolemic mice.
@en
Targeted nanoparticles contain ...... in hypercholesterolemic mice.
@nl
type
label
Targeted nanoparticles contain ...... in hypercholesterolemic mice.
@en
Targeted nanoparticles contain ...... in hypercholesterolemic mice.
@nl
prefLabel
Targeted nanoparticles contain ...... in hypercholesterolemic mice.
@en
Targeted nanoparticles contain ...... in hypercholesterolemic mice.
@nl
P2093
P2860
P921
P1476
Targeted nanoparticles contain ...... in hypercholesterolemic mice.
@en
P2093
Devram Ghorpade
Gabrielle Fredman
George Kuriakose
Jaclyn Milton
Mauro Perretti
Omid Farokzhad
Raymond Chiasson
Stefano Spolitu
P2860
P304
P356
10.1126/SCITRANSLMED.AAA1065
P407
P577
2015-02-01T00:00:00Z